For the past 20 years in its annual Special 301 Reports, the US has consistently criticized countries that do not have compulsory licensing standards that Big Pharma likes, that threaten to issue compulsory licenses, or that have actually had the temerity to issue a compulsory license… Despite its many complaints, veiled threats, and backroom maneuvers against compulsory licenses, the USTR’s bark has been much, much louder than it’s bite.